Alaunos Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,290 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 676-700 of 1,000 matching filings.

Per page
25
Current page
28
DEFA14A File 001-33038

DEFA14A

Filing date
15 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
15 May 2015
Reporting date
11 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79364

SC 13G/A filing

Filing date
15 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 May 2015
Reporting date
05 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
07 May 2015
Reporting date
05 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
07 May 2015
Reporting date
07 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
07 May 2015
Reporting date
05 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33038

DEFA14A

Filing date
30 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33038

DEF 14A

Filing date
30 Apr 2015
Reporting date
17 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
27 Apr 2015
Reporting date
27 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
02 Apr 2015
Reporting date
27 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
01 Apr 2015
Reporting date
01 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B7 File 333-201826

424B7

Filing date
01 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
30 Mar 2015
Reporting date
30 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33038

CT ORDER filing

Filing date
20 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
26 Feb 2015
Reporting date
26 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Feb 2015
Reporting date
22 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Feb 2015
Reporting date
09 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
12 Feb 2015
Reporting date
10 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Feb 2015
Reporting date
09 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79364

RANDAL J. KIRK SC 13DA NO 6 2-9-2015 (ZIOPHARM ONCOLOGY, INC)

Filing date
10 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
04 Feb 2015
Reporting date
03 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-201826

424(B)(5)

Filing date
04 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .